Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX-2 selective Inhibitor etoricoxib.

Curtis, Sean P; Ko, Amy T; Bolognese, James A; Cavanaugh, Paul F; Reicin, Alise S

Curtis, Sean P; Ko, Amy T; Bolognese, James A; Cavanaugh, Paul F; Reicin, Alise S.

Affiliation

Curtis SP; Merck Research Laboratories, Rahway, NJ 07065, USA.

Curr Med Res Opin ; 22(12): 2365-74, 2006 Dec.

Article in En | MEDLINE | ID: mdl-17265571

Subject(s)

Cyclooxygenase 2 Inhibitors/adverse effects; Pyridines/adverse effects; Sulfones/adverse effects; Thrombosis/chemically induced; Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Arthritis, Rheumatoid/drug therapy; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diclofenac/adverse effects; Etoricoxib; Humans; Osteoarthritis/drug therapy; Randomized Controlled Trials as Topic; Thrombosis/epidemiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Sulfones / Thrombosis / Cyclooxygenase 2 Inhibitors Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Curr Med Res Opin Year: 2006 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links